J Hardt1, H-J Buhr2, C Klinger2, S Benz3, K Ludwig4, J Kalff5, S Post6. 1. Chirurgische Klinik, Universitätsmedizin Mannheim (UMM), Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland. 2. Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV), Berlin, Deutschland. 3. Chirurgische Klinik, Klinikum Sindelfingen-Böblingen, Böblingen, Deutschland. 4. Chirurgische Klinik, Klinikum Südstadt Rostock, Rostock, Deutschland. 5. Chirurgische Klinik, Universitätsklinikum Bonn (UKB), Bonn, Deutschland. 6. Chirurgische Klinik, Universitätsmedizin Mannheim (UMM), Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland. stefan.post@umm.de.
Abstract
BACKGROUND: Quality assessment in surgery is gaining in importance. Although sporadic recommendations for quality indicators (QI) in oncological colon surgery can be found in the literature, these are usually not systematically derived from a solid evidence base. Moreover, reference ranges for QI are unknown. OBJECTIVE: The aim of this initiative was the development of evidence-based QI for oncological colon resections by an expert panel invited by the German Society of General and Visceral Surgery (DGAV). Reference ranges from the literature and reference values from the Study, Documentation, and Quality Center (StuDoQ)|Colon Cancer Register were compared in order to deduce recommendations which are tailored to the German healthcare system. RESULTS: Based on the most recent scientific evidence and agreed by expert consensus, five QI for oncological colon surgery were defined and evaluated according to the QUALIFY tool. Mortality, MTL30 (mortality, transfer to another acute care hospital, or length of stay ≥30 days), anastomotic leakage requiring reintervention, surgical site infections necessitating reopening of the wound and ≥12 lymph nodes in the specimen qualified as QI owing to their relevance, scientific nature, and practicability. Based on the results of the systematic literature search and the statistical analysis of the StuDoQ|Colon Cancer Register, preliminary reference values are proposed for each QI. CONCLUSION: The presented set of QI seems appropriate for quality assessment of oncological colon surgery in the context of the German healthcare system. The validity of the QI and the reference values must be reviewed within the framework of their implementation. The StuDoQ|Colon Cancer Register provides a suitable infrastructure for collecting clinical data for quality assessment and risk adjustment.
BACKGROUND: Quality assessment in surgery is gaining in importance. Although sporadic recommendations for quality indicators (QI) in oncological colon surgery can be found in the literature, these are usually not systematically derived from a solid evidence base. Moreover, reference ranges for QI are unknown. OBJECTIVE: The aim of this initiative was the development of evidence-based QI for oncological colon resections by an expert panel invited by the German Society of General and Visceral Surgery (DGAV). Reference ranges from the literature and reference values from the Study, Documentation, and Quality Center (StuDoQ)|Colon Cancer Register were compared in order to deduce recommendations which are tailored to the German healthcare system. RESULTS: Based on the most recent scientific evidence and agreed by expert consensus, five QI for oncological colon surgery were defined and evaluated according to the QUALIFY tool. Mortality, MTL30 (mortality, transfer to another acute care hospital, or length of stay ≥30 days), anastomotic leakage requiring reintervention, surgical site infections necessitating reopening of the wound and ≥12 lymph nodes in the specimen qualified as QI owing to their relevance, scientific nature, and practicability. Based on the results of the systematic literature search and the statistical analysis of the StuDoQ|Colon Cancer Register, preliminary reference values are proposed for each QI. CONCLUSION: The presented set of QI seems appropriate for quality assessment of oncological colon surgery in the context of the German healthcare system. The validity of the QI and the reference values must be reviewed within the framework of their implementation. The StuDoQ|Colon Cancer Register provides a suitable infrastructure for collecting clinical data for quality assessment and risk adjustment.
Entities:
Keywords:
Colon cancer; Colorectal cancer register; Reference values; Risk adjustment
Authors: Ruben Veldkamp; Esther Kuhry; Wim C J Hop; J Jeekel; G Kazemier; H Jaap Bonjer; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio M Lacy Journal: Lancet Oncol Date: 2005-07 Impact factor: 41.316
Authors: Gea A Gooiker; Nikki E Kolfschoten; Esther Bastiaannet; Cornelis J H van de Velde; Eric H Eddes; Erwin van der Harst; Theo Wiggers; Frits R Rosendaal; Rob A E M Tollenaar; Michel W J M Wouters Journal: J Surg Oncol Date: 2013-09-20 Impact factor: 3.454
Authors: C A Bertelsen; A U Neuenschwander; J E Jansen; A Kirkegaard-Klitbo; J R Tenma; M Wilhelmsen; L A Rasmussen; L V Jepsen; B Kristensen; I Gögenur Journal: Br J Surg Date: 2016-01-18 Impact factor: 6.939
Authors: Vassiliki L Tsikitis; David L Larson; Bruce G Wolff; Gregory Kennedy; Nancy Diehl; Rui Qin; Eric J Dozois; Robert R Cima Journal: J Am Coll Surg Date: 2009-01 Impact factor: 6.113
Authors: Ditte Louise E Munkedal; Søren Laurberg; Rikke Hagemann-Madsen; Katrine J Stribolt; Søren R P Krag; Philip Quirke; Nicholas P West Journal: Dis Colon Rectum Date: 2016-10 Impact factor: 4.585
Authors: Kai S Lehmann; Carsten Klinger; Johannes Diers; Heinz-Johannes Buhr; Christoph-Thomas Germer; Armin Wiegering Journal: BJS Open Date: 2021-11-09